Literature DB >> 30213832

Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor.

Andrea Biondi1,2, Gunnar Cario3, Paola De Lorenzo4,5, Anders Castor6, Valentino Conter4, Veronica Leoni4, Virginie Gandemer7, Rob Pieters8, Jan Stary9, Gabriele Escherich10, Myriam Campbell11, Andishe Attarbaschi12, Chi-Kong Li13, Ajay Vora14, Jutta Bradtke15, Vaskar Saha16, Maria Grazia Valsecchi5, Martin Schrappe3.   

Abstract

Entities:  

Keywords:  Philadelphia chromosome; acute lymphoblastic leukemia (ALL); pre-tyrosine kinase inhibitors (TKIs)

Mesh：

Substances：

Year:  2018        PMID： 30213832      PMCID： PMC6312020          DOI： 10.3324/haematol.2018.199422

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Treatment of acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; William E Evans
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

2.  Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.

Authors:  Maurizio Aricò; Martin Schrappe; Stephen P Hunger; William L Carroll; Valentino Conter; Stefania Galimberti; Atsushi Manabe; Vaskar Saha; André Baruchel; Kim Vettenranta; Keizo Horibe; Yves Benoit; Rob Pieters; Gabriele Escherich; Lewis B Silverman; Ching-Hon Pui; Maria Grazia Valsecchi
Journal:  J Clin Oncol       Date:  2010-09-27       Impact factor: 44.544

3.  'Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985-2000)'.

Authors:  M Schrappe; J Nachman; S Hunger; K Schmiegelow; V Conter; G Masera; R Pieters; C H Pui
Journal:  Leukemia       Date:  2010-02       Impact factor: 11.528

4.  Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.

Authors:  K R Schultz; A Carroll; N A Heerema; W P Bowman; A Aledo; W B Slayton; H Sather; M Devidas; H W Zheng; S M Davies; P S Gaynon; M Trigg; R Rutledge; D Jorstad; N Winick; M J Borowitz; S P Hunger; W L Carroll; B Camitta
Journal:  Leukemia       Date:  2014-01-20       Impact factor: 11.528

5.  Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

Authors:  M Schrappe; A Reiter; M Zimmermann; J Harbott; W D Ludwig; G Henze; H Gadner; E Odenwald; H Riehm
Journal:  Leukemia       Date:  2000-12       Impact factor: 11.528

6.  Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

Authors:  Kirk R Schultz; D Jeanette Pullen; Harland N Sather; Jonathan J Shuster; Meenakshi Devidas; Michael J Borowitz; Andrew J Carroll; Nyla A Heerema; Jeffrey E Rubnitz; Mignon L Loh; Elizabeth A Raetz; Naomi J Winick; Stephen P Hunger; William L Carroll; Paul S Gaynon; Bruce M Camitta
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

7.  Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).

Authors:  Michael J Burke; Qing Cao; Barb Trotz; Brenda Weigel; Ashish Kumar; Angela Smith; Michael R Verneris
Journal:  Pediatr Blood Cancer       Date:  2009-12-15       Impact factor: 3.167

8.  Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.

Authors:  Kirk R Schultz; W Paul Bowman; Alexander Aledo; William B Slayton; Harland Sather; Meenakshi Devidas; Chenguang Wang; Stella M Davies; Paul S Gaynon; Michael Trigg; Robert Rutledge; Laura Burden; Dean Jorstad; Andrew Carroll; Nyla A Heerema; Naomi Winick; Michael J Borowitz; Stephen P Hunger; William L Carroll; Bruce Camitta
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544

9.  Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  M Aricò; M G Valsecchi; B Camitta; M Schrappe; J Chessells; A Baruchel; P Gaynon; L Silverman; G Janka-Schaub; W Kamps; C H Pui; G Masera
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

10.  Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study.

Authors:  Andrea Biondi; Martin Schrappe; Paola De Lorenzo; Anders Castor; Giovanna Lucchini; Virginie Gandemer; Rob Pieters; Jan Stary; Gabriele Escherich; Myriam Campbell; Chi-Kong Li; Ajay Vora; Maurizio Aricò; Silja Röttgers; Vaskar Saha; Maria Grazia Valsecchi
Journal:  Lancet Oncol       Date:  2012-08-14       Impact factor: 41.316
View more
  4 in total

Review 1.  Management of CNS Disease in Pediatric Acute Lymphoblastic Leukemia.

Authors:  Jennifer L McNeer; Kjeld Schmiegelow
Journal:  Curr Hematol Malig Rep       Date:  2022-01-13       Impact factor: 3.952

2.  Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols.

Authors:  Gunnar Cario; Veronica Leoni; Valentino Conter; Andishe Attarbaschi; Marketa Zaliova; Lucie Sramkova; Gianni Cazzaniga; Grazia Fazio; Rosemary Sutton; Sarah Elitzur; Shai Izraeli; Melchior Lauten; Franco Locatelli; Giuseppe Basso; Barbara Buldini; Anke K Bergmann; Jana Lentes; Doris Steinemann; Gudrun Göhring; Brigitte Schlegelberger; Oskar A Haas; Denis Schewe; Swantje Buchmann; Anja Moericke; Deborah White; Tamas Revesz; Martin Stanulla; Georg Mann; Nicole Bodmer; Nira Arad-Cohen; Jan Zuna; Maria Grazia Valsecchi; Martin Zimmermann; Martin Schrappe; Andrea Biondi
Journal:  Haematologica       Date:  2019-10-10       Impact factor: 9.941

3.  Use of tyrosine kinase inhibitors for paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia: a systematic review and meta-analysis.

Authors:  Min Chen; Yiping Zhu; Yunzhu Lin; Tianzi Tengwang; Lingli Zhang
Journal:  BMJ Open       Date:  2021-01-19       Impact factor: 2.692

Review 4.  The Use of Inhibitors of Tyrosine Kinase in Paediatric Haemato-Oncology-When and Why?

Authors:  Agnieszka Kaczmarska; Patrycja Śliwa; Monika Lejman; Joanna Zawitkowska
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.